IGF1 and sarcopenia: 2019 clinical study conducted in Beijing, it was found that serum inflammatory markers, such as TNF-α, TNF-like weak inducer of apoptosis (TWEAK), IL-18, were significantly elevated in sarcopenia patients, while insulin-like growth factor 1 (IGF-1) and adiponectin, which are associated with metabolism, were significantly lower.